Skip to main content

The importance of early diagnosis: influenza and cardiac initiatives

15 Jun 2023
Central 4
Quality, transformation and innovation , Supporter session

This two-part session will focus on early diagnosis in flu and heart failure.

We will focus on the importance of diagnosing flu patients early and encouraging the audience to think about the state of current patient pathways and potential improvements. We will run through a 'test and treat' case study for flu, which will highlight the results from early diagnosis and treatment.

Heart failure patients are often diagnosed a late stage in their disease pathway following an admission to hospital, contributing to a significant burden to both patients and the healthcare system. This session will cover initiatives to improve the early detection of heart failure so that patients can have quicker access to evidence-based treatments and potentially avoid hospital admission.

This session is supported by Roche Diagnostics.

Dr. Ashton Harper, Head of Medical Affairs - Roche
Dr Jim Moore, President Primary Care Cardiovascular society - Cardiovascular Society
Marc Jones, Project Manager - Health Call Solutions
Shirley Shinkfield, Project Manager - Innovation Agency - AHSN North West Coast
Sue Wallace, Market Access Manager Infectious Diseases - Roche Diagnostics Ltd
Tommy Hoare, Analyst - Unity Insights
Dr Yusuf Shamsee, GP partner - Oaklands Health Centre